Macromolecular weight specificity in covalent binding of bromobenzene.
Bromobenzene is a hepatotoxicant that causes centrilobular necrosis. Pretreatment of animals with 3-methylcholanthrene decreases and phenobarbital pretreatment enhances the hepatotoxic action of this compound. We have investigated the macromolecular weight specificity of the covalent interactions of bromobenzene with liver macromolecules following incubation of [14C]bromobenzene in isolated hepatocytes. Hepatocytes were prepared from Fischer-344 rats treated for 3 days with 3-methylcholanthrene, phenobarbital, or normal saline. After a 1-hr incubation, total covalent binding, as measured by sodium dodecyl sulfate-equilibrium dialysis, was twofold less in hepatocytes from 3-methylcholanthrene-treated rats and sixfold greater in hepatocytes from phenobarbital-treated rats, as compared to hepatocytes from control animals. Analysis of the arylated macromolecules by electrophoresis on 15% sodium dodecyl sulfate-polyacrylamide disc gels indicated that in the first 1 to 3 min of incubation substantial amounts of covalently bound radiolabel were associated with macromolecules of between 20,000 and 40,000. The amount of radioactivity associated with these macromolecules rapidly diminished in hepatocytes from control and 3-methylcholanthrene-treated animals. In hepatocytes from phenobarbital-treated animals, the amount of radioactivity associated with macromolecules, 20,000, increased throughout the incubation. The amount of radiolabel associated with macromolecules, 20,000, increased in all incubations. When nontoxic doses of phenylmethylsulfonyl fluoride, a specific inhibitor of serine proteases, were added to control hepatocytes incubated with [14C]-bromobenzene, the decrease in radioactivity associated with larger (greater than 20,000) macromolecules was inhibited and a corresponding lack of increase in radioactivity associated with smaller macromolecules was observed. In hepatocytes from phenobarbital-treated rats, either the rate of adduct formation with higher molecular weight macromolecules greatly exceeded the rate of their breakdown or the phenobarbital treatment compromised the degradation process. The toxicity induced by bromobenzene may result from the covalently bound material altering the biological function of macromolecules. The result of this study suggest that cellular degradation of the arylated macromolecules may be one mechanism of detoxification. Persistence of the arylated macromolecules within the cell may be associated with the toxic action of bromobenzene.
D000818:Animals; D001969:Bromobenzenes / Q000378:metabolism*; D002250:Carbon Radioisotopes; D008099:Liver / Q000378:metabolism; D046911:Macromolecular Substances; D008297:Male; D008748:Methylcholanthrene / Q000494:pharmacology; D008970:Molecular Weight; D010634:Phenobarbital / Q000494:pharmacology; D010664:Phenylmethylsulfonyl Fluoride / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344
D001969:Bromobenzenes; D002250:Carbon Radioisotopes; D046911:Macromolecular Substances; D011506:Proteins; D008748:Methylcholanthrene; D010664:Phenylmethylsulfonyl Fluoride; C032036:bromobenzene; D010634:Phenobarbital